Concor ® COR Beta-blockers reduce mortality and morbidity in symptomatic patients with heart failure with reduced ejection fraction (HFrEF) 6 and are firmly established as part of standard treatment for chronic heart failure (CHF), alongside diuretics and angiotensin converting enzyme inhibitors (ACEIs). 6,7